These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Multivalent binding oligomers inhibit HIV Tat-TAR interaction critical for viral replication. Wang D; Iera J; Baker H; Hogan P; Ptak R; Yang L; Hartman T; Buckheit RW; Desjardins A; Yang A; Legault P; Yedavalli V; Jeang KT; Appella DH Bioorg Med Chem Lett; 2009 Dec; 19(24):6893-7. PubMed ID: 19896372 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA. Lalonde MS; Lobritz MA; Ratcliff A; Chamanian M; Athanassiou Z; Tyagi M; Wong J; Robinson JA; Karn J; Varani G; Arts EJ PLoS Pathog; 2011 May; 7(5):e1002038. PubMed ID: 21625572 [TBL] [Abstract][Full Text] [Related]
13. Modeling of HIV-1 TAR RNA-ligand complexes. Mitrasinovic PM; Tomar JS; Nair MS; Barthwal R Med Chem; 2011 Jul; 7(4):301-8. PubMed ID: 21574948 [TBL] [Abstract][Full Text] [Related]
14. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein. Aboul-ela F; Karn J; Varani G J Mol Biol; 1995 Oct; 253(2):313-32. PubMed ID: 7563092 [TBL] [Abstract][Full Text] [Related]
15. Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components. Likhoshvai VA; Khlebodarova TM; Bazhan SI; Gainova IA; Chereshnev VA; Bocharov GA BMC Genomics; 2014; 15 Suppl 12(Suppl 12):S1. PubMed ID: 25564443 [TBL] [Abstract][Full Text] [Related]
16. RNA conformation in the Tat-TAR complex determined by site-specific photo-cross-linking. Wang Z; Rana TM Biochemistry; 1996 May; 35(20):6491-9. PubMed ID: 8639596 [TBL] [Abstract][Full Text] [Related]
17. Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules. Mei HY; Cui M; Heldsinger A; Lemrow SM; Loo JA; Sannes-Lowery KA; Sharmeen L; Czarnik AW Biochemistry; 1998 Oct; 37(40):14204-12. PubMed ID: 9760258 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures. Rounseville MP; Lin HC; Agbottah E; Shukla RR; Rabson AB; Kumar A Virology; 1996 Feb; 216(2):411-7. PubMed ID: 8607271 [TBL] [Abstract][Full Text] [Related]
19. Probing interaction of a fluorescent ligand with HIV TAR RNA. Qi L; Zhang J; He T; Huo Y; Zhang ZQ Spectrochim Acta A Mol Biomol Spectrosc; 2017 Feb; 173():93-98. PubMed ID: 27611591 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 2-phenylquinolones targeted at Tat/TAR recognition. Manfroni G; Gatto B; Tabarrini O; Sabatini S; Cecchetti V; Giaretta G; Parolin C; Del Vecchio C; Calistri A; Palumbo M; Fravolini A Bioorg Med Chem Lett; 2009 Feb; 19(3):714-7. PubMed ID: 19109014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]